Read + Share
Xu R. Response to the letter titled "Comment on associations of semaglutide with
first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes:
Target trial emulation using nationwide real-world data in the US". Alzheimers Dement 2025;21:e14581.
PMID: 40356039
|
 |
|
